{"cluster": 37, "subcluster": 1, "abstract_summ": "Transient elevation of APLA from the viral illness may play a role in thrombosis associated with COVID-19.The severe form of COVID-19 share several clinical and laboratory features with four entities gathered under the term \u201chyperferritinemic syndrome\u201d and including macrophage activation syndrome (MAS), adult-onset Still's disease (AOSD), catastrophic anti-phospholipid syndrome (CAPS) and septic shock.Coronavirus Disease 2019 (COVID\u201019) is a newly emerging infectious disease caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102).The current case report provides clinical data of relevance to the largely unexplored question of the immunologic complications of COVID-19 in patients with a pre-existing inflammatory state.Infection caused by novel coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) has been associated with coagulopathy.We present a case of severe refractory thrombocytopenia in a 51-year-old woman with a history of long-standing systemic lupus erythematosus and antiphospholipid syndrome who presented with hemoptysis in the setting of COVID-19 infection.", "title_summ": "Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review).Coronavirus Disease 2019 (COVID-19) Infection Associated With Antiphospholipid Antibodies and Four-Extremity Deep Vein thrombosis in a Previously Healthy FemaleCOVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?Cold agglutinin disease and autoimmune hemolytic anemia with pulmonary embolism as a presentation of COVID-19 infectionViral Infections and Their Relationship with Catastrophic Antiphospholipid Syndrome: A Possible Pathogenic Mechanism of Severe COVID\u201019 Thrombotic ComplicationsAutoimmune haemolytic anaemia associated with COVID\u201019 infectionA Rare Case of Immune Thrombocytopenic Purpura Secondary to COVID\u201019Cold Agglutinin Autoimmune Hemolytic Anemia Associated with Novel Coronavirus (COVID\u201019)Severe refractory thrombocytopenia in a woman positive for coronavirus disease 2019 with lupus and antiphospholipid syndrome.", "title_abstract_phrases": "A Rare Case of Immune Thrombocytopenic Purpura Secondary to COVID\u201019Coronavirus Disease 2019 (COVID\u201019) is a newly emerging infectious disease caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102).Coronavirus Disease 2019 (COVID-19) Infection Associated With Antiphospholipid Antibodies and Four-Extremity Deep Vein thrombosis in a Previously Healthy FemaleInfection caused by novel coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) has been associated with coagulopathy.Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review).The severe acute respiratory syndrome coronavirus 2 (SARS\u2011CoV\u20112) is a novel \u03b2 coronavirus that is the etiological agent of the pandemic coronavirus disease 2019 (COVID\u201119) that at the time of writing (June 16, 2020) has infected almost 6 million people with some 450,000 deaths.Severe refractory thrombocytopenia in a woman positive for coronavirus disease 2019 with lupus and antiphospholipid syndrome.Viral Infections and Their Relationship with Catastrophic Antiphospholipid Syndrome: A Possible Pathogenic Mechanism of Severe COVID\u201019 Thrombotic ComplicationsThe disease caused by SARS\u2010CoV\u20102 (COVID\u201019) has different presentations and outcomes."}